期刊文献+

类泛素蛋白与肝癌 被引量:3

Ubiquitin-like proteins and hepatocellular carcinoma
下载PDF
导出
摘要 类泛素蛋白是一类与泛素有类似空间结构及酶修饰系统的蛋白质,它们在调节蛋白质功能中发挥着重要作用。类泛素蛋白主要通过对底物蛋白进行类泛素化修饰而发挥核质转运、转录调节、稳定蛋白质、应激反应以及细胞周期调控等多种生物学功能。近年来有大量的研究表明类泛素蛋白功能失调与肝癌的发生、增殖、凋亡以及血管新生等过程密切相关;并且在抗肿瘤药物的研究中也发现,通过调控类泛素化修饰过程可以改变化疗药物的抗肿瘤作用,进而影响肝癌的化疗敏感性,这表明类泛素蛋白可能成为一个新的肿瘤防治靶点。探究类泛素蛋白在肝癌发生、发展中的作用机制对诊断和治疗肝癌有着重要作用。 Ubiquitin-like proteins are structurally similar to ubiquitin. These proteins are processed, activated, conjugated, and released from conjugates by enzymatic steps that are similar to the corresponding mechanisms for ubiquitin. Ubiquitin-like proteins regulate a wide array of cellular processes through modification processes, such as nuclear-cytosolic transport, transcriptional regulation, protein stability, response to stress, and progression through the cell cycle. A large number of recent studies have found dysfunctional ubiquitin-like proteins in hepatocellular carcinoma. These proteins are important in tumorigenesis, cell proliferation, apoptosis, and angiogenesis. Anticancer drug studies revealed that regulating protein modification by using ubiquitin-like proteins may alter the anti-tu-mor effects of chemotherapy and thus influence the chemosensitivity of hepatocellular carcinoma. Results indicate that ubiquitin-like proteins may become a new target for cancer therapy. The mechanism of ubiquitin-like proteins in tumorigenesis and hepatocellular car-cinoma progression is of great significance in the diagnosis and treatment of hepatocellular carcinoma.
作者 晏琛 邵江华
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第14期933-937,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81360325) 江西省科技支撑计划项目(编号:20121BBG70029)资助~~
  • 相关文献

参考文献1

二级参考文献22

  • 1Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol[J]. J Clin Gastro- enterol, 2010, 44(4):239-245.
  • 2Oiang L, Huikai L, Butt K, etal. Factors associated with disease sur- vival after surgical resection in Chinese patients with hepatocellular carcinoma[J]. WorldJ Surg, 2006, 30(3):439-445.
  • 3Martelli G, Dei S, Lambert C, et al. Inhibkion of P-glycopro- tein-mediated Mulfidrug Resistance (MDR) by N,N-bis (cyclohexa- nol)amine aryl esters: Further restriction of molecular flexibility maintains high potency and efficacy[J]. Bioorg Med Ghem Lett, 2010.
  • 4Burg D, RiepsaameJ, Pont C, et al. Pepfide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity andJNK signaling[J]. Biochem Pharmacol, 2006, 71(3): 268-277.
  • 5Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, et al. Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases[J]. Cancer Lett, 2010, 295 (2) :135-143.
  • 6Sun LR, ZhongJL, Cui SX, et aL Modulation of P-glycoprotein ac- tivity by the substituted quinoxallnone compound Q A3 in adriamy- cin-resistant K562/A02 cells[J]. Pharmacol Rep, 2010, 62(2): 333-342.
  • 7Ling X, He X, Apontes P, et al. Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein surviving[J]. AmJ Transl Res, 2009, 1 (4) :393-405.
  • 8Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer[J]. Methods Mol Biol, 2010, 596:47-76.
  • 9Kumk O, Basaga H. Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis[J]. Apoptosis, 2006, 11 (10):1661-1675.
  • 10Qia s, Wang H, Chen X. Reversal of HCC drug resistance by us- ing hammerhead ribozymes against mulfidrug resistance 1 gene[J]. J Huazhong Univ Sci Technolog Med Sci, 2005, 25(6):662-664.

共引文献5

同被引文献42

  • 1Urn TH,Kim H,Oh BK,et a/.Aberrant CpG island hyperme- thylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis [J].J Hepatol, 2011,54 (5) : 939-947.
  • 2Liu W,He F,Jiang Y.Network-based discovery of gene sig- nature for vascular invasion prediction in HCC[J].J Hepatol, 2012,56(6) : 1420-1429.
  • 3Xiaojian H,Min C,Tao H.Lentivirus-mediated RNAi knock- down of the gap junction protein,Cx43,attenuates the de- velopment of vascular restenosis following balloon injury[J].Int J Mol Med, 2015,35 (4) : 855-892.
  • 4Marrero JA.Muhidisciplinary management of hepatoceltular carcinoma:where are we today?[J].Semin Liver Dis,2013, 33(Suppl 1) :3-10.
  • 5Wang C,Zhang Z,Li L,et a/.S100A11 is a migration-relat- ed protein in laryngeal squamous cell carcinoma[J].Int J Med Sci, 2013,10(11) : 1552-1559.
  • 6Bedford L,Lowe J,Dick LR,et a/.Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets[J].Nat Rev Drug Discov, 2011,10( 1 ) : 29-46.
  • 7Schmidtke G,Aichem A,Groettrup M.FAT10ylation as a signal for proteasomal degradation[J].Biochim Biophys Acta, 2014,1843(1) :97-102.
  • 8Zhao Y, Brickner JR, Majid MC,et a/.Crosstalk between u- biquitin and other post-translational modifications on chromatin during double-strand break repair [J].Trends Cell Biol, 2014,24(7) :426-434.
  • 9Wang J, Cai S, Chen Y.M echanism of E1 -E2 interaction for the inhibition of Ubl adenylation[J].J Biol Chem, 2010, 285(43) : 33457-33462.
  • 10Zhang ZY,Wu YQ,Luo H,et a/.The effect of nuclear fac- tor of activated T-cells (NFAT) in kidney I/R mediated by C5a/C5aR[J].Int J Clin Exp Med,2015,18 (9) : 15535- 15541.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部